Erudio Healtherudio.com
Drug
atezolizumab
2 HCP commentary reports on clinical trials studying atezolizumab. Each report covers what clinicians said in public about one trial, with the source behind every view.
| Trial | Indication | Phase | Statements | HCP sources | Size | Updated | Preview |
|---|---|---|---|---|---|---|---|
| IMpassion050 NCT03726879 · Hoffmann-La Roche | HER2-positive early breast cancer | Phase 3 | 175 | 16 | Standard | Oct 31, 2026 | Preview |
| SKYSCRAPER-03 NCT04513925 · Hoffmann-La Roche | locally advanced, unresectable stage III NSCLC | Phase 3 | 122 | 39 | Focused | Oct 31, 2026 | Preview |